Getting a GLP-1 medication covered by insurance depends on why it’s being prescribed, what type of insurance you have, and how thoroughly your doctor documents the medical need. Coverage for diabetes is relatively straightforward. Coverage for weight loss is harder to secure but increasingly possible, especially through larger employers. Here’s how to navigate each pathway.
Why Your Diagnosis Matters More Than the Drug
Insurance companies decide whether to cover a GLP-1 based primarily on the FDA-approved indication your doctor writes on the prescription. When prescribed for type 2 diabetes, medications like semaglutide and tirzepatide are covered by most commercial plans and Medicare Part D with standard copays. The friction starts when the same drugs are prescribed for weight management.
Many insurance plans treat weight loss medications as optional benefits, not required coverage. Employer plans in particular often exclude all weight loss drugs to keep premiums down. Medicare historically has not covered GLP-1s prescribed solely for weight loss, though that is beginning to change. Medicaid coverage varies widely: as of early 2026, only 13 states cover GLP-1s for weight loss.
There are newer covered indications beyond diabetes and weight loss that can open doors. If your doctor prescribes a GLP-1 to reduce cardiovascular risk in someone with established heart disease and a BMI of 27 or higher, or to treat moderate-to-severe obstructive sleep apnea in someone with obesity, those uses are FDA-approved and generally coverable under standard pharmacy benefits. Liver disease related to metabolic dysfunction (sometimes called MASH) is another recognized indication for certain GLP-1s. If any of these conditions apply to you, make sure your doctor codes the prescription accordingly.
Employer Plan Coverage Is Growing Fast
If you get insurance through your job, coverage depends on whether your employer opted in to weight loss drug benefits. In 2025, about 19 percent of large firms covered GLP-1s for weight loss. That number skews heavily by company size: 43 percent of firms with 5,000 or more employees now cover them, up from 28 percent in 2024. Midsize firms (1,000 to 4,999 employees) sit at 30 percent, while smaller large employers (200 to 999 employees) are at 16 percent.
If you work for a large company and aren’t sure about your plan’s coverage, call the number on the back of your insurance card and ask specifically whether your formulary includes GLP-1 agonists for weight management. HR departments can also tell you whether obesity medication is an excluded benefit. Some employers have added coverage in the last year, so even if you checked before, it’s worth asking again.
What Your Doctor Needs to Document
Almost every insurance plan requires prior authorization before covering a GLP-1. This means your doctor submits paperwork proving you meet the plan’s medical criteria. The specifics vary by insurer and indication, but the general requirements follow a pattern.
For weight management, most plans want to see a BMI at or above a certain threshold (typically 30, or 27 with a weight-related condition), plus evidence that you’ve tried lifestyle changes for at least six months, including dietary modifications and increased physical activity. Your doctor needs to document these efforts in your chart. If there’s a medical reason you can’t wait six months (for example, a rapidly worsening condition), that justification must also be documented.
For cardiovascular risk reduction, insurers typically require documentation of a prior heart attack, stroke, or peripheral artery disease, along with a BMI of 27 or higher. A prescription from or in consultation with a cardiologist or similar specialist strengthens the case. For obstructive sleep apnea, the bar includes a BMI of 35 or higher, a sleep study confirming moderate-to-severe OSA within the past two years, and evidence that you’ve tried or been unable to tolerate a CPAP machine.
The common thread: the more thoroughly your medical records reflect your condition and what you’ve already tried, the better your chances. If you’ve been working with a dietitian, attending a weight management program, or tracking blood pressure and blood sugar, make sure all of it is in your chart before your doctor submits the prior authorization.
How to Appeal a Denial
If your prior authorization is denied, you have the right to appeal, and it’s worth doing. The process has two stages.
An internal appeal goes directly to your insurance company. Your doctor submits a letter of medical necessity explaining why the medication is appropriate for you, along with your medical records and any supporting clinical literature. This letter should spell out your diagnosis, your treatment history, why alternatives haven’t worked or aren’t appropriate, and what the expected benefit of the GLP-1 is. If you have overlapping conditions (say, insulin resistance plus obesity, or diabetes plus cardiovascular disease), make sure every relevant diagnosis is included. Insurers sometimes deny claims because the documentation was incomplete, not because the patient didn’t qualify.
If the internal appeal fails, you can request an external appeal. This sends your case to an independent third party that reviews the evidence and makes a binding decision your insurance company must follow. You don’t need a lawyer for this. Your doctor’s office handles most of the paperwork, but you can strengthen the appeal by including the latest clinical evidence supporting GLP-1 use for your specific situation.
Medicare Coverage: What’s Changing
Medicare Part D now covers GLP-1s prescribed for diabetes, cardiovascular risk reduction, and obstructive sleep apnea through standard formulary channels. For weight loss specifically, Medicare has historically excluded these drugs, but a new program is on the way.
The Medicare GLP-1 Bridge is a temporary demonstration program running from July 1, 2026, through December 31, 2027. It will cover Wegovy (both injection and tablets), Zepbound, and Foundayo for eligible Part D beneficiaries who need the medication to reduce excess body weight. This program operates outside the normal Part D benefit structure. Your provider will submit a prior authorization to a central processor rather than to your Part D plan directly.
One important detail: if you qualify for coverage under the standard Part D benefit (for example, because you have cardiovascular disease or sleep apnea), your prescription goes through your regular Part D plan, not the Bridge program. The Bridge is specifically for beneficiaries whose only qualifying use is weight reduction.
Savings Programs If Insurance Falls Short
Manufacturer savings cards can significantly reduce your out-of-pocket cost, but they come with restrictions. Wegovy’s savings card, for example, lets commercially insured patients pay as little as $25 per month, with the manufacturer covering up to $100 of the remaining cost per monthly fill. If you’re uninsured or your commercial plan doesn’t cover the drug, a limited-time self-pay offer brings the price to $199 per month for the first two fills (available through June 2026 for new patients).
The major catch: these programs exclude anyone enrolled in a federal or state healthcare program, including Medicare, Medicaid, TRICARE, and VA benefits. Even if you’re Medicare-eligible and enrolled in an employer retiree plan, you can’t use the manufacturer card. You also can’t use it if you participated in the same savings offer in the past year.
Zepbound and other GLP-1 manufacturers run similar programs with comparable restrictions. These cards are most useful as a bridge while you work through the prior authorization or appeal process with your insurer, or if your plan covers the drug but leaves you with a high copay.
A Step-by-Step Approach
- Check your formulary first. Call your insurer or log into your plan’s portal to see if GLP-1s are listed and under what conditions they’re covered.
- Identify every qualifying diagnosis. Weight loss alone may not be covered, but weight loss plus sleep apnea, cardiovascular risk, or prediabetes changes the calculation.
- Document lifestyle efforts. If your plan requires a six-month history of diet and exercise attempts, start tracking now and make sure your doctor records it.
- Ask your doctor to submit prior authorization with thorough records. Incomplete documentation is the most common reason for denials that could have been approvals.
- Appeal every denial. Internal first, then external. Include a detailed letter of medical necessity and all supporting records.
- Use manufacturer savings cards to lower costs while you wait for coverage decisions, if you’re commercially insured.